Successful treatments for Alzheimer's disease have eluded the pharmaceutical industry — every large drug company has had at least one failure, and many small companies have gone out of business trying to find a cure for the tricky mental ailment, In the Pipeline's Derek Lowe says. But there could be a way to get some good out of all those failures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.